Innoplexus Proudly Announces the Launch of its Product iPlexusTM, at Bio-IT World, 2017

Tuesday, May 23, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

BOSTON, May 23, 2017 /PRNewswire/ --

Innoplexus is unveiling iPlexus TM at Bio-IT, 2017 Booth #355.

 iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence
and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. It has modules for Competitive Intelligence, Clinical Intelligence, Regulatory Intelligence, Gene and Intervention landscapes.

     (Logo: http://mma.prnewswire.com/media/515193/Innoplexus_Logo.jpg )

The platform leverages our proprietary CAAV™ framework to crawl, aggregate, analyse, index and visualise hundreds of terabytes of scientific data across hundreds of clinical trial databases, biological databases, major patent offices, congresses, theses, forums and regulatory bodies. It offers confidence that the researcher will not miss any significant information that might impact his/her research later. There is value in getting information readily and as soon as it's available - more so in research, as it can totally change the path of the work that happens next. A researcher, now with its help, can get real-time access and understanding of the wide variety of research data, and benefit from understanding their cross-pollination.

It offers an easy to use, intuitive, secure, cloud-based system which generates intelligence across datasets using machine learning models, natural language processing and advanced text analytics. Our patent pending data extraction algorithms leverage our Ontologise™ framework to transform raw unstructured data into a structured form. Making data and insights instantly and continuously available takes the pain out of data collection, curation and analysis, eventually helping to make informed decisions better and faster.

iPlexus TM homes in 35+ million scientific articles, more than 150+ clinical trials databases, over 250+ biological databases, along with major international congresses, patents, etc.

Innoplexus has innovated in the way data is crawled (collected) from thousands of data sources across hundreds of formats of HTMLs, PDFs and other document types. Innoplexus' technology is now able to leverage Deep Learning and Computer Vision to extract specific data points from unstructured, unlabelled, continuous text as well.

In addition, it is able to disambiguate between entities eg. different authors with same names and leverage our ontology to discover relationships between them.

About InnoplexusTM  

Innoplexus is a technology and product development company focused on AI and advanced analytics. We automate the collection and curation of data using cutting-edge technologies such as network analysis, ontologies, computer vision and entity normalisation. Our decision support enables organizations with access to data and insights that are real time, comprehensive and cost effective.

Media Contact:  Akhilesh Choudhary Email: akhilesh.choudhary@innoplexus.com Contact No: +91-9890004080/+91-20-66527300

.

SOURCE Innoplexus Consulting Services Private Limited



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook